Key facts
- This page summarizes Richard H. Scheller's Form 4 filing for Oric Pharmaceuticals, Inc. (ORIC).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 May 2021, 19:29.
Richard H. Scheller - 20 May 2021 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)
- Reporting relationship
- Director
- Issuer ticker
- ORIC
- Reported as of
- 20 May 2021
- Net transaction value
- -$50,036
- SEC form
- 4
- Accepted by SEC
- 24 May 2021, 19:29:24 UTC
- Prior SEC filing
- 18 May 2021
- Next SEC filing
- 25 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christian Kuhlen, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard H. Scheller filed Form 4 for Oric Pharmaceuticals, Inc. (ORIC) on 24 May 2021.
Change
- Previous filing in this sequence was filed on 18 May 2021.
- Current net transaction value: -$50,036.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ORIC
transaction
Common Stock
Sale
- Transaction value
- $16,528
- Shares
- -659
- Change %
- -1.6%
- Price
- $25.08
- Shares after
- 40,423
- Date
- 20 May 2021
- Ownership
- Direct
- Footnotes
- F1, F2
ORIC
transaction
Common Stock
Sale
- Transaction value
- $31,008
- Shares
- -1,231
- Change %
- -3%
- Price
- $25.19
- Shares after
- 39,192
- Date
- 21 May 2021
- Ownership
- Direct
- Footnotes
- F1, F3
ORIC
transaction
Common Stock
Sale
- Transaction value
- $2,500
- Shares
- -100
- Change %
- -0.26%
- Price
- $25.00
- Shares after
- 39,092
- Date
- 24 May 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2
Represents the weighted average share price of an aggregate total of 659 shares sold in the price range of $25.00 to $25.15 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
Represents the weighted average share price of an aggregate total of 1,231 shares sold in the price range of $25.00 to $25.35 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.